Product Description
Mycopenolic Acide Delayed tablets UPS 360Mg
Mycophenolic acid is an antimetabolite immunosuppressant indicated forprophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant.
Powerful Immunosuppressive SupportThese delayed-release tablets are specifically designed for immunosuppressive therapy, targeting the prevention of organ transplant rejection in adults. Their unique formulation ensures gradual drug release, promoting stable blood concentrations and reduced gastrointestinal side effects. Only available by prescription, this product supports treatment regimens for post-transplant patients under medical supervision.
Convenience and Quality in PackagingWith a robust packaging standard, each tablet is individually blister-packed and securely housed in a carton box, providing integrity during storage and transport. Bulk orders start at 5,000 tablets, ideal for institutions or export. Quality assurance aligns with manufacturer and regulatory specifications, ensuring safety and authenticity from production through delivery.
FAQs of Mycopenolic Acide Delayed tablets UPS 360Mg:
Q: How should Mycophenolic Acid Delayed-Release Tablets USP 360 mg be taken?
A: The tablets should be swallowed whole, without crushing or chewing, and taken exactly as prescribed by your healthcare professional. Always follow medical instructions for dosing and never modify your regimen without consulting your doctor.
Q: What is the primary benefit of using this medication?
A: These tablets act as a potent immunosuppressant, significantly reducing the risk of organ transplant rejection. By modulating the immune system, they help maintain the success of the transplanted organ and improve long-term outcomes.
Q: When is this product recommended for use?
A: Mycophenolic Acid Delayed-Release Tablets USP 360 mg are recommended for adult patients who have undergone organ transplantation and need medication to prevent immune-mediated rejection of the new organ.
Q: What precautions should be followed while storing these tablets?
A: Tablets should be stored below 25C, in a dry place, and protected from light and moisture. Proper storage ensures the drugs stability and effectiveness throughout its 36-month shelf life.
Q: Where can I obtain this medication?
A: This product is available through licensed exporters, suppliers, and traders in India, typically in bulk orders. It requires a valid prescription and is distributed to authorized medical facilities or registered buyers.
Q: What is the minimum order quantity and how is it packaged?
A: The minimum order is 5,000 tablets, packaged in high-quality blister packs within carton boxes. Each box ensures safe transport and maintains product integrity until delivered to the end user.